Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc..
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a powerful treatment option for individuals with B cell malignancies but have yet to achieve success in treating acute myeloid leukemia (AML) due to a lack of safe targets. Here we leveraged an atlas of publicly available RNA-sequencing data of over 500,000 single cells from 15 individuals with AML and tissue from 9 healthy individuals for prediction of target antigens that are expressed on malignant cells but lacking on healthy cells, including T cells. Aided by this high-resolution, single-cell expression approach, we computationally identify colony-stimulating factor 1 receptor and cluster of differentiation 86 as targets for CAR-T cell therapy in AML. Functional validation of these established CAR-T cells shows robust in vitro and in vivo efficacy in cell line- and human-derived AML models with minimal off-target toxicity toward relevant healthy human tissues. This provides a strong rationale for further clinical development.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Nature biotechnology - 41(2023), 11 vom: 04. Nov., Seite 1618-1632 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 13.11.2023 Date Revised 04.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41587-023-01684-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354204742 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354204742 | ||
| 003 | DE-627 | ||
| 005 | 20240305231857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41587-023-01684-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1317.xml |
| 035 | |a (DE-627)NLM354204742 | ||
| 035 | |a (NLM)36914885 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gottschlich, Adrian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.11.2023 | ||
| 500 | |a Date Revised 04.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer Nature America, Inc. | ||
| 520 | |a Chimeric antigen receptor T cells (CAR-T cells) have emerged as a powerful treatment option for individuals with B cell malignancies but have yet to achieve success in treating acute myeloid leukemia (AML) due to a lack of safe targets. Here we leveraged an atlas of publicly available RNA-sequencing data of over 500,000 single cells from 15 individuals with AML and tissue from 9 healthy individuals for prediction of target antigens that are expressed on malignant cells but lacking on healthy cells, including T cells. Aided by this high-resolution, single-cell expression approach, we computationally identify colony-stimulating factor 1 receptor and cluster of differentiation 86 as targets for CAR-T cell therapy in AML. Functional validation of these established CAR-T cells shows robust in vitro and in vivo efficacy in cell line- and human-derived AML models with minimal off-target toxicity toward relevant healthy human tissues. This provides a strong rationale for further clinical development | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Thomas, Moritz |e verfasserin |4 aut | |
| 700 | 1 | |a Grünmeier, Ruth |e verfasserin |4 aut | |
| 700 | 1 | |a Lesch, Stefanie |e verfasserin |4 aut | |
| 700 | 1 | |a Rohrbacher, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Igl, Veronika |e verfasserin |4 aut | |
| 700 | 1 | |a Briukhovetska, Daria |e verfasserin |4 aut | |
| 700 | 1 | |a Benmebarek, Mohamed-Reda |e verfasserin |4 aut | |
| 700 | 1 | |a Vick, Binje |e verfasserin |4 aut | |
| 700 | 1 | |a Dede, Sertac |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Katharina |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Dhoqina, Dario |e verfasserin |4 aut | |
| 700 | 1 | |a Märkl, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Robinson, Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Sendelhofert, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Schulz, Heiko |e verfasserin |4 aut | |
| 700 | 1 | |a Umut, Öykü |e verfasserin |4 aut | |
| 700 | 1 | |a Kavaka, Vladyslav |e verfasserin |4 aut | |
| 700 | 1 | |a Tsiverioti, Christina Angeliki |e verfasserin |4 aut | |
| 700 | 1 | |a Carlini, Emanuele |e verfasserin |4 aut | |
| 700 | 1 | |a Nandi, Sayantan |e verfasserin |4 aut | |
| 700 | 1 | |a Strzalkowski, Thaddäus |e verfasserin |4 aut | |
| 700 | 1 | |a Lorenzini, Theo |e verfasserin |4 aut | |
| 700 | 1 | |a Stock, Sophia |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Philipp Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Dörr, Janina |e verfasserin |4 aut | |
| 700 | 1 | |a Seifert, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Cadilha, Bruno L |e verfasserin |4 aut | |
| 700 | 1 | |a Brabenec, Ruben |e verfasserin |4 aut | |
| 700 | 1 | |a Röder, Natalie |e verfasserin |4 aut | |
| 700 | 1 | |a Rataj, Felicitas |e verfasserin |4 aut | |
| 700 | 1 | |a Nüesch, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Modemann, Franziska |e verfasserin |4 aut | |
| 700 | 1 | |a Wellbrock, Jasmin |e verfasserin |4 aut | |
| 700 | 1 | |a Fiedler, Walter |e verfasserin |4 aut | |
| 700 | 1 | |a Kellner, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Beltrán, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Herold, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Paquet, Dominik |e verfasserin |4 aut | |
| 700 | 1 | |a Jeremias, Irmela |e verfasserin |4 aut | |
| 700 | 1 | |a von Baumgarten, Louisa |e verfasserin |4 aut | |
| 700 | 1 | |a Endres, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Subklewe, Marion |e verfasserin |4 aut | |
| 700 | 1 | |a Marr, Carsten |e verfasserin |4 aut | |
| 700 | 1 | |a Kobold, Sebastian |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature biotechnology |d 1996 |g 41(2023), 11 vom: 04. Nov., Seite 1618-1632 |w (DE-627)NLM08998398X |x 1546-1696 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2023 |g number:11 |g day:04 |g month:11 |g pages:1618-1632 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41587-023-01684-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2023 |e 11 |b 04 |c 11 |h 1618-1632 | ||